Brief: Anixa Biosciences Announces Poster Presentation On Ovarian Cancer CAR-T Clinical Trial At ESMO Gynaecological Cancers Congress 2025
09/06/2025 13:42
June 9 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES ANNOUNCES POSTER PRESENTATION ON OVARIAN CANCER CAR-T CLINICAL TRIAL AT THE ESMO GYNAECOLOGICAL CANCERS CONGRESS 2025 Source text: ID:nPn3c6JYma Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine